By Andy Blom, TES Washington Editor While we wait and wonder about the presidency, the pandemic, promised vaccines, pending Brexit and Jeffrey Toobin’s p— er never mind,,, anyway while all that remains up in the air, Free Market advocates and organizations will keep on working, doing the critical policy work that makes a difference. […]
Top Page Links
Prescription Drug “Rebates” Raise Prices, Limit Drug Choice, and Make Patients Sicker
By Erik Sass Anti-competitive practices in the prescription drug marketplace like “rebate walls” routinely cost ordinary Americans thousands of dollars every year while restricting patient access to medications. These costs and restrictions will only grow more onerous in years to come, unless the incoming Biden administration acts swiftly to take on these anti-market arrangements. […]
Global Voices Sound Alarm Against Price Controls for Medicines
Courtesy Austrian Economics Center The Austrian Economics Center (AEC) has expressed its concern with the intention of the US government to establish an International Reference Pricing (IRP) for medicines. Indeed, in recent years, the US has stayed on the drug pricing issue with key proposals in the form of executive orders by President […]
Good ideas that benefit the masses are the keys to becoming rich
By Dr. Rainer Zitelmann, TES Contributor A son of Turkish immigrants has become a multi-billionaire thanks to an innovative Covid-19 vaccine. Wealth is the reward for anyone who has good ideas that create benefits for the masses – regardless of their background. “Ideas Will Make Your Rich” is the name of one of […]
The Pentagon wants a new fighter. How will it prevent another F-35 debacle?
By Chris Nagavonski, TES Contributor The Department of Defense is still scrambling to address potentially-crippling flaws in the Lockheed Martin F-35 fifth-generation fighter jet, even as the number of aircraft produced for the United States and allied nations approaches 600. While the program drags on, the Air Force is already designing and testing a […]
Health, Patents and Innovation: The Pharmaceutical Industry in Latin America
By Santiago Remón; Reviewer, Franco M. López, Fundacion BASES Introduction We have long understood health as a basic human need. The pharmaceutical industry, that business sector dedicated to the manufacture, preparation and marketing of medicinal chemicals for the treatment and prevention of diseases, has played a very important role in health care for […]
The Assault On Early COVID-19 Treatment: Congressional Hearing Speaks Volumes about Our Failed Pandemic Response
By Donald Pompan, MD, and Michael M. Jacobs, MD, MPH The Senate Homeland Security Committee convened a hearing on 19 November 2020 Chaired by Senator Ron Johnson (R-WI) to examine “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution.” This hearing was not televised nationally and was sparsely attended, even by its own […]
Washington Beyond the Headlines: Alcohol Consumption Guidelines Lowered (Again)
By Andy Blom, TES Washington Editor More elections! There are still undecided seats in Congress and the runoff for control of the Senate in Georgia, which is recently looking more purple than red — something hard to imagine a decade ago. The role of outside money probably has something to do with it: by […]
The Global Democratization of Finance
By Bradley Hook & Adam Traidman Technological advances, a changing global paradigm, and the COVID-19 pandemic have combined in unprecedented ways to alter the way we use, move, and invest money. Whether the focus is on emerging economies and the unbanked or new ways to raise investments from a global pool of potential […]
Refuting Dr. Ashish Jha’s “Dangerous” and Deceptive Testimony
By Erik Sass, TES Editor-in-Chief There comes a time when a public figure’s statements are so wrong, so dangerous, and so grossly offensive that they must be rebutted and debunked one by one. This is the case with the Senate testimony and subsequent New York Times op-ed and media appearances by Dr. Ashish Jha, […]